Literature DB >> 21695744

Anxiety, depression and quality of life after cancer diagnosis: what psychosocial variables best predict how patients adjust?

Nicholas Hulbert-Williams1, Richard Neal, Val Morrison, Kerry Hood, Clare Wilkinson.   

Abstract

OBJECTIVE: Significant numbers of cancer patients suffer distress, reduced quality of life and various other psychological problems. Evidence regarding psychological predictors of these outcomes is inconsistent. This study explored a range of predictors using an established psychological framework to identify the most important predictors of cancer adjustment, and when these are best assessed for optimal outcome prediction.
METHODS: One hundred sixty newly diagnosed breast, colorectal, lung and prostate cancer patients completed questionnaires after diagnosis and at 3- and 6-month follow-up. Measures included personality, illness cognitions, emotion, coping and outcome (anxiety, depression and quality of life).
RESULTS: Between 47-74% of variance in psychosocial outcome was explained although large proportions were accounted for by clinical factors, demographics and earlier levels of anxiety, depression and quality of life. Of the psychological variables, cognitive appraisals featured more consistently then either emotions or coping.
CONCLUSIONS: There are clear and consistent predictors of negative psychosocial outcome that could be used in clinical practice to risk-assess and monitor patients for adjustment difficulties. The finding that appraisals were more predictive of outcome than emotions and coping may inform the development of psychological interventions for cancer patients.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adjustment; anxiety; cancer; depression; oncology; quality of Life

Mesh:

Year:  2011        PMID: 21695744     DOI: 10.1002/pon.1980

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  23 in total

1.  A Validation Study of the Mini-IPIP Five-Factor Personality Scale in Adults With Cancer.

Authors:  Laura M Perry; Michael Hoerger; Lisa A Molix; Paul R Duberstein
Journal:  J Pers Assess       Date:  2019-08-12

2.  Influence of Treatment Caused Impairments on Anxiety and Depression in Patients with Cancer of the Esophagus or the Esophagogastric Junction.

Authors:  Thomas Kiefer; Dorothea Krahl; Carsten Hirt; Heinz Völler; Lorenz Völkel; Georg Daeschlein
Journal:  J Gastrointest Cancer       Date:  2020-03

3.  Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.

Authors:  Lesley Stafford; Fiona Judd; Penny Gibson; Angela Komiti; G Bruce Mann; Michael Quinn
Journal:  Support Care Cancer       Date:  2015-01-06       Impact factor: 3.603

4.  Predictors of quality of life among ethnically diverse breast cancer survivors.

Authors:  Ellen G Levine; Grace Yoo; Caryn Aviv
Journal:  Appl Res Qual Life       Date:  2016-01-28

5.  Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for early post-treatment breast cancer survivors.

Authors:  Stephanie J Sohl; Beverly Levine; Nancy E Avis
Journal:  Qual Life Res       Date:  2014-07-05       Impact factor: 4.147

6.  Psychological resilience contributes to low emotional distress in cancer patients.

Authors:  Jung-Ah Min; Sujung Yoon; Chang-Uk Lee; Jeong-Ho Chae; Chul Lee; Kyo-Young Song; Tae-Suk Kim
Journal:  Support Care Cancer       Date:  2013-04-20       Impact factor: 3.603

7.  Experiences of colorectal cancer patients in the 2-years post-diagnosis and patient factors predicting poor outcome.

Authors:  Christine L Paul; Emilie Cameron; Christopher Doran; David Hill; Finlay Macrae; Mariko L Carey; Rob W Sanson-Fisher
Journal:  Support Care Cancer       Date:  2016-07-16       Impact factor: 3.603

8.  Systematic screening and assessment of psychosocial well-being and care needs of people with cancer.

Authors:  Bojoura Schouten; Bert Avau; Geertruida Trudy E Bekkering; Patrick Vankrunkelsven; Jeroen Mebis; Johan Hellings; Ann Van Hecke
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

9.  Reliability and Validity of the Newly Diagnosed Breast Cancer Stress Scale in the Greek Population.

Authors:  Maria Charalampopoulou; Konstantinos Syrigos; Evaggelos Filopoulos; Vasileios Megalooikonomou; Dimitrios Vlachakis; George Chrousos; Christina Darviri
Journal:  J Mol Biochem       Date:  2020-12-30

Review 10.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.